CB Pharma Acquisition Corp.
Exhibit 10.5
May 20, 2016
0 Xxxxxxxx Xxxxxx, 00xx Xxxxx
Xxx Xxxx, Xxx Xxxx 00000
EarlyBirdCapital, Inc.
000 Xxxxxxx Xxxxxx, 0xx Xxxxx
Xxx Xxxx, Xxx Xxxx 00000
Gentlemen:
Based on the contemporaneous due execution and delivery of (i) the Agreement dated as of even date herewith among certain Sellers (as specified therein), EJF Opportunities, LLC, Xxxxxxx X. Xxxxxx, Xxxx X. Aldeanueva, Xxxxxxx X. Xxxxxxxx Profit Sharing Plan and Xxxxx Xxxxxxx (collectively, the “Investors”), and CB Pharma Acquisition Corp. (“Company”) and (ii) the Insider Letters of the Investors, Xxxxxx X. Xxxx and Xxxxxxx X. Xxxxxxxx, each substantially in the form provided to each of the undersigned, the undersigned hereby agrees that with regard to its letter agreement with the Company, dated December 12, 2014, Section 12 is hereby deleted in its entirety. Additionally, upon approval of the matters set forth in Section 7.3 of the Agreement, Section 2(a), Section 2(c) and Section 13 shall be deleted in their entirety.
[Remainder of page intentionally left blank; signature page to follow.]
If the foregoing correctly sets forth our agreement, please so confirm by signing below in the space indicated.
| /s/ Xxxxxxx X. Xxxxxxxxx | |
| Foretress Biotech, Inc. |
| EARLYBIRDCAPITAL, INC. | CB PHARMA ACQUISITION CORP. | |||
| By: | /s/ Xxxxx Xxxxxxxx | By: | /s/ Xxxxxxx X. Xxxxxxxxx | |
| Title: | Chairman | Title: | CEO | |
[Insider Letter Amendment - Officers and Directors]
